Weight loss

Weight Loss

Surya Namaskar for weight loss: what the evidence actually shows

Dr. Himalay Agarwal

Dr. Himalay Agarwal

Consultant Internal Medicine

Surya Namaskar for weight loss is widely recommended, but the evidence behind it is thin. It is physical activity, and the controlled research does not establish it as a dependable treatment for weight or metabolic health.

Two controlled trials carry the body-composition evidence. Both ran eight weeks, and neither establishes that the practice changes body composition more than doing nothing does. Anyone choosing the practice because it is free, familiar and needs no equipment is choosing reasonably. What they should not expect is an evidence base that matches the confidence of the claims around it.

Key Takeaways

  • Two eight-week trials, one in India and one in Thailand, are the only controlled tests of Surya Namaskar on its own for body composition.
  • Neither shows a clear advantage over no exercise: the Thai trial found no difference in BMI or body fat, and the Indian trial never compared its Surya Namaskar group directly with its no-exercise group.
  • In the one study that measured both, Surya Namaskar ran at a lower intensity than self-paced treadmill walking at all three paces tested.
  • At the slowest pace it did not clearly reach moderate intensity. At the two faster paces it did.
  • No adequate trial has isolated its effect on blood sugar, lipids or blood pressure, and the safety cautions come from an official board rather than from trials.

What the two controlled trials found

The first trial, run in Pune, studied Indian women aged 20 to 40 with a BMI between 25.1 and 34.9 kg/m², assigning them to a modified chair-based Surya Namaskar sequence, treadmill walking, circuit training or no exercise for eight weeks. Sessions lasted roughly 45 to 60 minutes. How often participants trained each week is not clearly reported, and the rounds were not fixed: participants continued until they rated their exertion at 7 out of 10.

Inside the Surya Namaskar group, weight fell 1.6% and body-fat percentage fell 3.7%, from 41.9% to 40.3%, at P<0.01. A bioimpedance device, which estimates composition from the body's resistance to a small current, put the visceral-fat rating 9.3% lower and its muscle-mass estimate 2.2% higher, a rise that was not statistically significant (p=0.06). Those are the numbers that circulate.

The comparison that matters is the one between groups, and that is where the paper stops being usable. Its discussion reports the differences in weight and BMI as not statistically significant.

Its results section lists weight, BMI and body-fat percentage among the variables that did differ between groups, and its Table 4 agrees: across the four groups, the differences in weight (p=0.0003), BMI (p=0.0002) and body-fat percentage (p=0.006) were significant, while muscle mass was not (p=0.55). But each of those is a single test across all four groups at once. It shows that at least one group differed from the others, not that Surya Namaskar beat no exercise, and the paper reports no direct comparison between those two groups.

A within-group change tells you only that a group's average changed during a period of training, not that the training caused it. The control group also started lighter, with a mean BMI of 26.6 against 29.0 in the Surya Namaskar group. No reader can establish from this paper whether Surya Namaskar outperformed no exercise on weight, BMI or body fat.

The second trial used a cleaner design. Published in 2025 by a group at the University of Phayao in Thailand, it randomised 44 overweight and obese female university students to eight weeks of Surya Namaskar or no exercise.

It was registered with the Thai Clinical Trials Registry, its outcome assessor was blinded, and the yoga group trained three sessions a week, supervised in the first week and then at home following a video for the remaining seven. Its sample size was calculated for perceived stress rather than body composition, and the authors note it was underpowered to detect some differences between groups.

Its results fall into two kinds:

  • Within the group: BMI and perceived stress fell while flexibility, grip strength, leg strength and VO2max rose.
  • Against the control group: only forward-back flexibility and perceived stress differed significantly, at p=0.015 and p=0.009. BMI and body fat did not.

That leaves the second trial as the clearer of the two on the question readers actually ask: against a control group, eight weeks of Surya Namaskar produced no significant difference in BMI or body fat.

Why the first trial's design limits what it shows

Five problems limit what its numbers can be read to mean:

  • Allocation to the four groups followed a predictable rotating sequence rather than a concealed random one, so whoever enrolled a participant could anticipate which group she would enter.
  • The authors do not report whether the people measuring the outcomes knew which group each participant belonged to, whether adverse events were tracked, or whether the trial was registered before it began.
  • The reported numbers disagree with each other. The article gives 119 people as enrolled in one place and 103 as recruited in another, a gap of 16 that it never reconciles, and 87 finished. Thirty-two of the 119 therefore did not complete the trial, a figure that includes women the paper counted as dropouts for attending too few sessions.
  • Its calculation of how many participants were needed was generic rather than aimed at a specified change in body composition, so the trial was not built to detect the effect it is quoted for.
  • Independent researchers later challenged its statistical conclusions and could not reproduce parts of the analysis, in a published letter that asked for the paper to be withdrawn.

The way this trial is usually quoted has a further problem. It did include active comparators, treadmill walking and circuit training. But a trial too small to detect a difference cannot demonstrate the absence of one, so where it reports no difference against those comparators, that is not evidence of equivalence. It is evidence that this trial could not tell. Treating it as settled evidence is how Indian weight-loss myths outlive the research behind them.

How much energy does Surya Namaskar use?

Less than self-paced moderate treadmill walking at all three paces, in the one study that measured both. A 2019 crossover study put ten inactive adults with obesity through 10-minute bouts at three speeds, measuring energy use from the air they breathed rather than estimating it. METs are multiples of the energy a person uses sitting quietly, so 3.28 METs is a little over three times resting.

Measured intensity and energy use over 10 minutes, by pace:

  • 6 seconds per pose: 3.28 METs, about 39 kcal
  • 4 seconds per pose: 3.64 METs, about 45 kcal
  • 3 seconds per pose: 4.22 METs, energy use not reported
  • Self-paced moderate treadmill walking: 5.29 METs, 64 kcal

The study shows two things:

  • Pace changes the intensity: at the slowest tempo, 3.28 METs was not significantly above the 3 METs that marks moderate intensity (p=0.13), while the two faster tempos were.
  • Equal duration does not mean equal energy use: ten minutes at the 4-second pace used about 45 kcal against 64 for walking.

Figures as high as 7.4 METs also circulate, from a review of extremely small laboratory work. That outlier exceeds the treadmill figure above, which is why the comparison here is stated for one study rather than for the literature as a whole.

What the evidence shows on blood sugar and lipids

No adequate controlled trial isolates what Surya Namaskar does to fasting glucose, HbA1c, insulin resistance, lipids or blood pressure in Indian adults. The metabolic claims are therefore untested rather than tested and disproved.

The study usually offered in their place tested something else. A 184-person Indian trial in adults at high risk of diabetes reported changes in waist circumference, post-meal glucose and LDL cholesterol, with no change in fasting glucose. Nothing in that design allows the results to be assigned to the Surya Namaskar component, for two reasons:

  • It was registered only after it had begun.
  • Its intervention was a multi-component yoga programme that included other postures, breathing practices, meditation and relaxation alongside Surya Namaskar.

When four practices are delivered as one package, any improvement belongs to the package. Isolating one requires a trial that varies it alone.

Safety cautions on record

The published cautions come from institutional guidance rather than from trials. India's Yoga Certification Board advises:

  • Avoiding the practice with coronary artery disease, spinal injury, hernia or peptic ulcer
  • Medical consultation for back conditions
  • Avoiding it at the onset of menstruation
  • Practising with care, under a yoga expert's guidance, during pregnancy
  • Checking the contraindications of each of the eight component postures before starting

Those are official positions on what to avoid, not measurements of how often harm occurs.

The trial evidence cannot fill that gap. The Indian trial excluded uncontrolled metabolic, systemic and orthopaedic conditions and used a chair-modified sequence. The Thai trial enrolled university students. Standard Surya Namaskar therefore remains largely untested in adults with hypertension or joint and spinal limitations, the group most likely to be reading about it.

Broader yoga research found no difference in serious harm against exercise, but its adverse-event reporting is incomplete and not specific to this sequence. For the medical conditions the board names, its advice is to avoid the practice, not to modify it. Raised blood pressure, knee problems and metabolic conditions are not on its list, so those need clinician supervision, following the same principle as when weight loss should be medically supervised.

What to expect from Surya Namaskar

Surya Namaskar's measured energy cost came in below self-paced moderate treadmill walking at all three paces in the study that measured both, which places it closer to moderate activity than to a weight-loss intervention. At the faster tempos the measured intensity passed the 3 METs that marks moderate activity, and the practice needs nothing but floor space. What walking has that Surya Namaskar does not is a dose-response evidence base, at least for mortality.

If you choose to practise it, the evidence supports a few practical points:

  • At 4 seconds per pose or faster it reached moderate intensity in the one study that measured it. At 6 seconds per pose it did not clearly do so.
  • At the two paces with an energy figure, ten minutes of Surya Namaskar used about 39 to 45 kcal against 64 for ten minutes of self-paced walking. Equal time is not equal exercise.
  • With coronary artery disease, a spinal injury, a hernia or a peptic ulcer, the Yoga Certification Board's advice is to avoid it.
  • The board also advises avoiding it at the onset of menstruation, and practising with care under a yoga expert's guidance during pregnancy.
  • With back or knee problems, raised blood pressure or a metabolic condition, check with a clinician before starting.

The two trials leave these questions open:

  • Durable weight loss
  • Waist change
  • Objectively measured fat or lean mass
  • Metabolic markers
  • The number of rounds or the pace worth using
  • Injury rates and adherence
  • Effects in men
  • Anything beyond the eight weeks both trials ran

No adequately powered, registered trial has compared standard Surya Namaskar against walking, cycling or resistance training matched for duration and energy use. Measuring body composition and blood markers under clinician review shows what a practice is actually doing rather than leaving it to guesswork, and that is how Voy's clinicians work. When activity leaves your weight unchanged, knowing what a blood panel can find that a diet plan can't is the next step.

Not sure whether your activity is changing the numbers that matter? A Voy clinician can review your body composition and blood markers. Book an assessment.

This article is for general information and education only and is not medical advice, diagnosis, or treatment. GLP-1 and other medications referenced are prescription-only and are appropriate only for certain people under the supervision of a qualified clinician. Do not start, stop, or change any medication based on this article. Please consult a registered medical practitioner about your individual circumstances. Information reflects what was available at the time of review and may change.

Related articles

Premium Star Icon

Join 25 Lakh members getting healthy

Doctor-backed weight loss support you can trust

Trustpilot

Trusted by 25 Lakh +
Customers

Still confused?

App Store
Download on theApp Store
Google Play
Get it onGoogle Play